心脏瓣膜16S rRNA基因PCR/测序用于感染性心内膜炎常规诊断
本研究比较了常规临床实践中瓣膜16S rRNA基因PCR/测序与传统IE诊断方法。既往抗生素暴露者分别为76%和11%(P<0.001)。61%血培养阴性IE患者瓣膜PCR/测序阳性。
要点
- 瓣膜16S rRNA基因PCR/测序在常规实践中对IE病原体鉴定有应用价值。
- 血培养阴性IE患者中61%瓣膜PCR/测序阳性。
- 既往抗生素暴露者瓣膜PCR/测序阳性率显著高于血培养。
核心结论
- 心脏瓣膜16S rRNA基因PCR/测序是血培养阴性IE患者瓣膜手术中病原体鉴定的有用诊断工具。
研究设计与样本
- 研究纳入2020年8月至2022年2月送至临床微生物实验室进行心脏瓣膜16S rRNA基因PCR/测序的受试者。
- 采用靶向16S rRNA基因V1至V3区域的PCR,根据包含PCR循环阈值值的算法进行Sanger和/或下一代测序(NGS,使用Illumina MiSeq)或报告为阴性。
主要发现
- 血培养和瓣膜16S rRNA基因PCR/测序的阳性率分别为55%和75%(P=0.06)。
- 既往抗生素暴露者中,血培养和瓣膜16S rRNA基因PCR/测序的阳性率分别为11%和76%(P<0.001)。
- 总体而言,61%的血培养阴性IE受试者瓣膜16S rRNA基因PCR/测序结果阳性。
临床怎么用
- 对于血培养阴性且接受瓣膜手术的IE患者,可考虑采用心脏瓣膜16S rRNA基因PCR/测序辅助病原体鉴定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sequencing is increasingly used for infective endocarditis (IE) diagnosis. Here, the performance of 16S rRNA gene PCR/sequencing of heart valves utilized in routine clinical practice was compared with conventional IE diagnostics. Subjects whose heart valves were sent to the clinical microbiology laboratory for 16S rRNA gene PCR/sequencing from August 2020 through February 2022 were studied. A PCR assay targeting V1 to V3 regions of the 16S rRNA gene was performed, followed by Sanger and/or next-generation sequencing (NGS) (using an Illumina MiSeq), or reported as negative, depending on an algorithm that included the PCR cycle threshold value. Fifty-four subjects, including 40 with IE, three with cured IE, and 11 with noninfective valvular disease, were studied. Thirty-one positive results, 11 from NGS and 20 from Sanger sequencing, were generated from analysis of 16S rRNA gene sequence(s). Positivity rates of blood cultures and 16S rRNA gene PCR/sequencing of valves were 55% and 75%, respectively (P = 0.06). In those with prior antibiotic exposure, positivity rates of blood cultures and 16S rRNA gene PCR/sequencing of valves were 11% and 76%, respectively (P < 0.001). Overall, 61% of blood culture-negative IE subjects had positive valve 16S rRNA gene PCR/sequencing results. 16S rRNA gene-based PCR/sequencing of heart valves is a useful diagnostic tool for pathogen identification in patients with blood culture-negative IE undergoing valve surgery in routine clinical practice.
引用
- Hong HL, Flurin L, Greenwood-Quaintance KE, et al. 16S rRNA Gene PCR/Sequencing of Heart Valves for Diagnosis of Infective Endocarditis in Routine Clinical Practice. J Clin Microbiol. 2023. PMID: 37436146. doi:10.1128/jcm.00341-23
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。